During Thursday’s Current trade, Shares of GrubHub Inc (NYSE:GRUB), lost -0.56% to $29.88.
GrubHub Inc. (GRUB), the leading takeout marketplace, declared financial results for the quarter ended June 30, 2015.
Second Quarter 2015 Highlights
The following results reflect the financial performance and key operating metrics of our business for the three months ended June 30, 2015 as contrast to the same period in 2014.
Second Quarter Financial Highlights
- Revenues: $88.0 million, a 47% year-over-year enhance from $60.0 million in the second quarter of 2014.
- Non-GAAP Adjusted EBITDA: $28.4 million, a 68% year-over-year enhance from $16.9 million in the second quarter of 2014.
- Net Income: $9.4 million, or $0.11 per diluted share, a 247% year-over-year enhance from $2.7 million, or $0.03 per diluted share, in the second quarter of 2014.
- Non-GAAP Net Income: $15.0 million, or $0.17 per diluted share, a 146% year-over-year enhance from $6.1 million, or $0.07 per diluted share.
GrubHub Inc., together with its auxiliaries, provides an online and mobile platform for restaurant pick-up and delivery orders in the United States. The company connects about 30,000 local restaurants with diners in about 800 cities. It operates GrubHub and Seamless Websites through grubhub.com and seamless.com.
Shares of Gentex Corporation (NASDAQ:GNTX), declined -0.25% to $16.23, during its current trading session.
Gentex Corporation ( GNTX) the Zeeland, Michigan-based manufacturer of automotive automatic-dimming rearview mirrors, automotive electronics, dimmable aircraft windows, and fire protection products, stated financial results for the three months ended June 30, 2015.
For the second quarter of 2015, the Company is happy to report net sales of $379.3 million, which was an enhance of 12% contrast to net sales of $338.4 million in the second quarter of 2014. The Company’s continued growth in sales has been accomplished despite worldwide light vehicle production that declined 1% in the second quarter of 2015 in the Company’s primary markets as compared to the second quarter of 2014, in addition to foreign currency fluctuations that accounted for about 1% of revenue headwind during the second quarter of 2015.
Gentex Corporation designs, develops, manufactures, and markets automatic-dimming rearview mirrors and electronics for the automotive industry; dimmable aircraft windows for the aviation industry; and commercial smoke alarms and signaling devices for the fire protection industry worldwide. The company offers automotive products, counting interior and exterior electrochromic automatic-dimming rearview mirrors; automotive electronics; and interior and exterior non-automatic-dimming rearview mirrors with electronic features for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, tier one automotive mirror manufacturers, and various aftermarket and accessory customers.
Prothena Corporation PLC (NASDAQ:PRTA), during its Thursday’s current trading session gained 1.64% to $67.99.
Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapy programs, recently stated financial results for the second quarter and first six months of 2015 and offered an update on its lead programs.
Second Quarter 2015 Highlights:
- In April, successfully raised aggregate net proceeds of $131.4 million through the issuance of 3,795,000 ordinary shares.
- In May, declared a contract with The Michael J. Fox Foundation for Parkinson`s Research to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson`s disease progression to facilitate therapeutic approaches, counting PRX002, targeting alpha-synuclein, a protein potentially involved in the onset and progression of Parkinson`s disease.
- In June, at oral presentations during the 2015 American Society for Clinical Oncology Annual Meeting and the 20thCongress of the European Hematology Association (EHA), stated updated clinical data from the multiple ascending dose portion of a Phase 1/2 trial demonstrating NEOD001-treated patients achieved more than double the cardiac and renal biomarker responses when contrast to historical data in patients treated solely with off-label standard of care.
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on the discovery, development, and commercialization of protein immunotherapy programs for the treatment of diseases that involve amyloid or cell adhesion in Ireland. The companys product pipeline comprises NEOD001, a product candidate that is in Phase III clinical trials to treat patients with AL amyloidosis, in addition to is in Phase I/II clinical trials for AL amyloidosis and persistent organ dysfunction. It is also developing PRX002 that is in Phase I clinical trials for the treatment of Parkinsons disease and other synucleinopathies; and PRX003, a monoclonal antibody for psoriasis and other inflammatory diseases.
Finally, NetScout Systems, Inc. (NASDAQ:NTCT), decreased -1.40%, to $39.54.
NetScout Systems, Inc. (NTCT), a market leader in service assurance solutions, will visit the Nasdaq MarketSite in Times Square following its recent $2.3 billion acquisition of Danaher’s Communications Business. The event will also assist commemorate the 30-year anniversary of NetScout’s founding, which occurred last year.
In honor of the occasion, Anil Singhal, Co-founder, President and CEO of NetScout, will ring the Opening Bell. Mr. Singhal will be joined by members of his senior administration team, senior engineering leaders and staff.
NetScout Systems, Inc., together with its auxiliaries, designs, develops, manufactures, markets, licenses, sells, and supports network, application, and service assurance solutions in the United States, Europe, Asia, and internationally. It offers performance analytics and operational intelligence solutions that facilitate the evolution toward new computing paradigms, such as virtualization, mobility, and cloud.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
